The U.S. Supreme Court on Thursday ruled unanimously to maintain access to the abortion pill mifepristone, which is used in nearly two-thirds of all U.S. abortions. The decision comes as a relief to providers and patients across the nation, but advocates warn the far-right-dominated court’s ruling on the FDA’s authority to regulate the pill was purely on procedural grounds, and could even offer a “roadmap” for future challenges. Justice Brett Kavanaugh wrote in the court’s decision, “The plaintiffs have sincere legal, moral, ideological, and policy objections,” suggesting the proper venue for their case could be with the president, lawmakers or federal regulators. We’ll have more on this ruling after headlines with professor Michele Goodwin.